Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07615738 · ClinicalTrials.gov registry record · NA
SpO2 Infant and Pediatric Study
A NA study, sponsored by GE Healthcare.
- Not yet
- Registry status
- NA
- Development phase
- 180
- Enrollment target
NCT07615738: Clinical Trial NA study, sponsored by GE Healthcare.
NCT07615738 is a NA study that has not yet begun recruiting, run by GE Healthcare. The registered enrollment target is 180 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07615738, a NA study, has not yet begun recruiting, sponsored by GE Healthcare.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
Study Summary
This study evaluates the pulse oximetry (SpO₂) sensor for clinical performance, form, and fit in hospitalized infants and children (28 days to 12 years). It compares SpO₂ measurements from the device to arterial oxygen saturation (SaO₂) values from arterial CO-oximetry, and assesses the reliability of usable data, performance across skin tones, and user feedback.
Primary Outcome
The collection of SpO2 percentage sensor data with simultaneous SaO2 values percentage from each subject enrolled in the study.
Interventions
- DEVICE SpO2 Sensor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2026-06-15 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What is known before NCT07615738 opens enrollment
NCT07615738 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 1 intervention - of which SpO2 Sensor is the first listed.
NCT07615738 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07615738 about?
NCT07615738 is a clinical study titled "SpO2 Infant and Pediatric Study". This study evaluates the pulse oximetry (SpO₂) sensor for clinical performance, form, and fit in hospitalized infants and children (28 days to 12 years). It compares SpO₂ measurements from the device to arterial oxygen saturation (SaO₂) values from arterial CO-oximetry, and assesses the reliability ...
What is the current status of trial NCT07615738?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2026-06-15. Estimated completion is 2027-12-31.
What interventions are being tested in trial NCT07615738?
The interventions under investigation include: SpO2 Sensor (DEVICE).
Who is sponsoring clinical trial NCT07615738?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07615738's enrollment target sits among peer trials
180 586th of 2000 higher than 1,397 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI